Robin Steinhorn, M.D., joined Children’s after a successful tenure as professor and chair of the Department of Pediatrics at the University of California, Davis School of Medicine and as Physician in Chief, University of California, Davis Children's Hospital. Previously, she was Vice Chair of the Department of Pediatrics and Chief of the Division of Neonatology at Northwestern University and the Ann & Robert H. Lurie Children's Hospital of Chicago.
Dr. Steinhorn's clinical and academic interests have focused primarily on the pulmonary vascular development of the fetus and newborn. Her translational work has spanned from in vitro studies to animal models and clinical trials. In addition to her own translational research program, Dr. Steinhorn has participated in numerous multi-center trials, which have helped define the clinical treatment of pulmonary hypertension in the neonatal period. She has been a charter member of three NIH study sections over the last 15 years. Her clinical research work has also addressed other topics such as harmonization of electronic health records for clinical research and telemedicine support of neonatal care in small rural hospitals.
Dr. Steinhorn was recently elected to the Council of the American Pediatric Society (2015-2020), and is currently completing a 5-year term on the American Board of Pediatrics (Neonatal Perinatal Medicine). She is an elected Fellow of the American Heart Association and a member of the Perinatal Research Society and American Thoracic Society. Dr. Steinhorn is an Associate Editor of the Journal of Pediatrics, and also serves as an Associate Editor for Pediatric Critical Care Medicine and on the editorial boards of American Journal of Respiratory and Critical Care Medicine, Pulmonary Circulation and the NEJM Journal Watch for Pediatric and Adolescent Medicine.
Additionally, Dr. Steinhorn is particularly passionate about mentoring faculty and supporting the growth and career development of young neonatologists and scientists, with several having developed their own funded laboratories and assumed division leadership positions.